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The 1995 Calman–Hine plan outlined radical reform of the UK’s cancer services with the aim of improving outcomes and reducing
inequalities in NHS cancer care. Its main recommendation was to concentrate care into the hands of site-specialist, multi-disciplinary
teams. This study aimed to determine if the implementation of Calman–Hine cancer teams was associated with improved processes
and outcomes of care for colorectal cancer patients. The design included longitudinal survey of 13 colorectal cancer teams in
Yorkshire and retrospective study of population-based data collected by the Northern and Yorkshire Cancer Registry and
Information Service. The population was all colorectal cancer patients diagnosed and treated in Yorkshire between 1995 and 2000.
The main outcome measures were: variations in the use of anterior resection and preoperative radiotherapy in rectal cancer,
chemotherapy in Dukes stage C and D patients, and five-year survival. Using multilevel models, these outcomes were assessed in
relation to measures of the extent of Calman–Hine implementation throughout the study period, namely: (i) each team’s degree of
adherence to the Manual of Cancer Service Standards (which outlines the specification of the ‘ideal’ colorectal cancer team) and (ii)
the extent of site specialisation of each team’s surgeons. Variation was observed in the extent to which the colorectal cancer teams in
Yorkshire had conformed to the Calman–Hine recommendations. An increase in surgical site specialisation was associated with
increased use of preoperative radiotherapy (OR¼1.43, 95% CI¼1.04–1.98, Po0.04) and anterior resection (OR¼1.43, 95%
CI¼1.16–1.76, Po0.01) in rectal cancer patients. Increases in adherence to the Manual of Cancer Service Standards was associated
with improved five-year survival after adjustment for the casemix factors of age, stage of disease, socioeconomic status and year of
diagnosis, especially for colon cancer (HR¼0.97, 95% CI¼0.94–0.99 Po0.01). There was a similar trend of improved survival in
relation to increased surgical site specialisation for rectal cancer, although the effect was not statistically significant (HR¼0.93, 95%
CI¼0.84–1.03, P¼0.15). In conclusion, the extent of implementation of the Calman–Hine report has been variable and its
recommendations are associated with improvements in processes and outcomes of care for colorectal cancer patients.
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Colorectal cancer occurs in over 34500 people in the UK each year
and it kills around 16000 of those diagnosed (Cancer Research UK,
2005). In the mid 1990s, it became clear that the UK survival rate
fell below the European average (Berrino et al, 1995) and that the
quality of NHS care varied considerably across the country (Bull
et al, 1997; Mella et al, 1997). In consequence, improving survival
and ensuring a high quality of care for all has become a top
priority for the Government.
The strategy by which the Government hoped to achieve this in
England and Wales was outlined in the 1995 Calman–Hine report
(Calman–Hine Report, 1995) and the subsequent NHS Cancer
Plan (The NHS Cancer Plan, 2000). These documents recom-
mended that care should be organised into the hands of site
specialists in each relevant discipline working together in multi-
disciplinary cancer teams (MDTs). Detailed specifications of whom
and how these teams should be composed were provided in the
1997 Improving Outcomes Guidance (IOG) in Colorectal Cancer
(NHS Executive, 1997).
These reforms were unusual, as they aimed to improve
outcomes through the reconfiguration of facilities and personnel,
rather than through the introduction of a new health technology.
The recommendations originated from data suggesting that high
workload (Schrag et al, 2002) or specialist (Birbeck et al, 2002;
McArdle and Hole, 2002; Smith et al, 2003) doctors offered better
outcomes than their low workload or generalist counterparts.
Unfortunately, however, the evidence available to substantiate this
theory is not conclusive (Kee et al, 1999; Parry et al, 1999) and, as a
consequence, not all within the health service subscribe to the idea
(Singh et al, 1997).
Despite the equivocal evidence base, however, the reforms have
been a flagship NHS policy and substantial resources have been
invested in their implementation. The aim of this population-
based longitudinal study was to quantify the extent to which the
Calman–Hine recommendations of multidisciplinary team forma-
tion and surgical site specialisation in colorectal cancer had been
translated into practice by 2000, in the Yorkshire region of the UK. Received 8 May 2006; revised 14 August 2006; accepted 14 August 2006
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sIn addition, the study sought to determine if these changes were, as
the Government intended, associated with improvements in the
outcome of colorectal cancer patients.
PATIENTS AND METHODS
All patients diagnosed with colorectal cancer (ICD10 codes C18,
C19 and C20) between 1995 and 2000 in the former Yorkshire
Regional Health Authority were identified via the Northern and
Yorkshire Cancer Registry Information Service (NYCRIS). Routi-
nely recorded information about patients’ disease and its manage-
ment was downloaded. Any patients for whom such information
was missing (due to death certificate only registration or who were
managed by their GP’s, privately or outside the region) were
excluded.
In 2000, 13 colorectal cancer teams provided cancer care within
the study region. All patients, identified via NYCRIS, were
allocated to a team based on their hospital of diagnosis or (before
1998) their initial hospital of attendance.
Assessment of Calman–Hine implementation
Two methods of assessing Calman–Hine implementation were
adopted. The first assessed the formation of multidisciplinary
teams and the second the move from general surgeons to site-
specialist management.
Growth of colorectal cancer teams In 2001, the Department of
Health published National Accreditation standards (Manual of
Cancer Service Standards, 2001) based on the original IOG that
detailed the criteria that the ‘ideal’ colorectal cancer team should
adhere to. To assess the growth of the study’s teams, a team score
based on each unit’s adherence to these criteria over time was
developed. A questionnaire was devised which asked whether each
criterion had been met in each year between 1995 and 2000. Each
team was then asked to complete the questionnaire for the time
period covered and, by determining the number (and percentage)
of standards that had been met in each year, charts of the time-
scale of team formation could be charted.
The move towards site specialisation Another measure of
implementation was the move towards site specialist surgical
care. The surgeon performing the main surgical procedure of each
patient was identified. The specialty of this surgeon was
determined by looking up their entries in the 2001
Medical Directory (Medical Directory, 2001) or on the website
specialistinfo.com (Specialistinfo.com, 2002). In both these
resources, the consultant cites their own specialist interests. If no
specialism could be identified, or doctors chose to define
themselves as general surgeons, they were allocated to a specialism
based on their annual median workload (n¼11). A threshold was
set for a colorectal specialist surgeon as one whose annual median
workload exceeded 24 new cases per year based on the IOG (NHS
Executive, 1997). The proportion of patients in each year and in
each team receiving their main surgery from either a self-declared
or high workload specialist was then calculated.
Statistical methods
Multilevel (random effects) binary logistic regression models were
used to assess how the Calman–Hine changes were associated with
care outcomes. Models were developed with the cancer team as a
random effect (at level 2), allowing for within-team correlation
among patient outcomes. All models were developed within the
MLwiN software (MLwiN version 2.02, 2005).
Main outcomes (dependant variables) were chosen based upon
recommendations given in the IOG document (NHS Executive,
1997). This document stated that (1) the use of systemic therapy
should be discussed with patients who possessed Dukes C or D
cancers and who were fit enough to tolerate it; (2) radiotherapy
should be used preoperatively for rectal cancer patients at high
risk of recurrence and (3) anterior resection (where possible)
should be the operation of choice in these patients. These measures
of patient health care were, therefore, all selected as dependant
variables in the form of binary outcomes (i.e., patients received the
recommended care, coded 1, or they did not, coded 0). As the
ultimate aim of Calman–Hine was to improve survival, multilevel
proportional hazards (frailty) models (Gilthorpe et al, 2002) were
used to assess survival at 5 years.
Covariates (explanatory variables) included age (per 10 year
increase), gender, the Townsend material deprivation score of each
patient (derived according to the enumeration district of residence
at diagnosis), year of diagnosis, stage at diagnosis (Dukes A and B,
C and D or unknown) and increases in either of the Calman–Hine
implementation scores (per 25% increase in team score or surgical
specialisation score). A Townsend score was unable to be allocated
to 200 patients. To ensure these individuals were included in the
model, they were allotted the mean Townsend score of the study
population. All continuous covariates were centred (i.e., each case
had the population mean of the variable arithmetically deducted
from it) to improve estimation procedures (Gilthorpe and
Cunningham, 2000).
Bivariate correlations among all covariates were examined to
assess potential problems due to collinearity, as such collinearity
might confound the analyses (Tu et al, 2001, 2005). Where strong
correlations were observed between time (year of diagnosis) and
the Calman–Hine implementation scores, analyses were under-
taken across two time periods – 1995 to 2000 and 1996 to 1998,
separately – in an attempt to limit the effect of collinearity. The
narrower time period of 1996–1998 was chosen because the
correlations between time and the Calman–Hine implementation
scores were reduced and this period also corresponded to the
period in which the main guidance documents about service
reform in colorectal cancer were published, and the rate of change
in practice towards the Calman–Hine recommendations should
have been greatest.
RESULTS
Study population
In total, 12358 patients were diagnosed with colorectal cancer in
the study area between 1995 and 2000. Of these, 810 were excluded
due to missing management information as they were managed
extra-regionally (n¼94), managed by their GP (n¼25), treated as
private patients (n¼481), death certificate only registrations
(n¼174) or had missing NYCRIS information (n¼36). This left
a study population of 11548 cases (93.4%). Characteristics of this
population are given in Table 1.
Degree of Calman–Hine implementation
Adherence to manual of cancer service standards Of the 13 teams,
nine completed questionnaires for the project. Figure 1 demon-
strates the rate of growth of these teams. Although there was a
definite change in practice over the study period, no team adhered
to all the requirements of team structure and function laid out in
the manual of cancer service standards by 2000.
Colorectal site specialisation A total of 142 surgeons performed
colorectal cancer surgery on the entire study population and the
overall annual median workload was seven cases per year (range
0.5–65). The annual median workload of the specialists among
them was 29 (range 1 to 65). Figure 2 illustrates the proportion of
patients receiving their surgery from such a specialist over the
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sstudy period. Even in the final year of the study, however, a
substantial proportion of patients (19%) failed to receive their
initial surgery from a colorectal specialist.
Change in process and outcomes according to extent of
Calman–Hine implementation
Use of chemotherapy in Dukes stage C and D colorectal cancer
patients Thirty-seven per cent of the Dukes stage C and D
population received some form of chemotherapy, although the rate
of use varied across teams and over time (Table 2). In 1995, the
median percentage of patient receiving such treatment was 34.0%
(range 18.0–53.8%). By 2000, this had increased to a median of
36.2% (range 18.2–51.8%).
The results of multilevel models, summarised in Table 3,
indicate what proportion of this change in practice was associated
with implementation of the Calman–Hine recommendations. In
models adjusting for casemix and year of diagnosis, a 25% increase
in team score was associated with an 8% decrease in the odds of
use of chemotherapy, although this was not statistically significant
(OR¼0.92, 95% CI¼0.83–1.03). The correlations were, however,
high in this model and so another was explored, with reduced
collinearity, for the time period 1996–1998. This demonstrated a
nonsignificant 16% increase in the odds of use of chemotherapy
in relation to 25% increases in team score (OR¼1.16, 95%
CI¼0.86–1.58). Collinearity had thus attenuated the association
towards and beyond the null.
In contrast, a 25% increase in specialisation was associated with
a significant 32% increased odds of a Dukes C/D patient receiving
chemotherapy (OR¼1.32, 95% CI¼1.02–1.69). In the shorter
duration, the trend was reduced to a nonsignificant 3% increase in
the odds of administration of chemotherapy (OR¼1.03, 95%
CI¼0.55–1.94). The impact of collinearity for this outcome,
therefore, confuses the findings.
Preoperative radiotherapy for rectal cancer During the full study
period, 16.5% of the rectal cancer population received preoperative
radiotherapy. In 1995, its median percentage use across the teams
was 0.0% (range 0.0–12.5%), and by 2000 this had increased to a
median of 17.1% (range 3.3–70.0%). Table 2 illustrates the change
in percentage administration across the teams and the study
period.
Models established to determine what proportion of the changes
in pratice were associated with the Calman–Hine implementation
are summarised in Table 4. An increase of 25% in the team score
was associated with 58% increased odds of use of preoperative
radiotherapy. However, there were again concerns over the high
correlation between team score and time (year of diagnosis), which
raises questions over the reliability of this assessment. Conse-
quently, a shorter duration model (1996–1998), with substantially
reduced collinearity, was explored. In this model, there was no
effect of a 25% increase in team score on the use of preoperative
radiotherapy (OR¼0.99, 95% CI¼0.75–13.2). This suggests there
was no genuine association between this covariate and the outcome.
Table 1 Characteristics of the study population
1995–2000 1996–1998
Characteristic n % n %
Tumour site
Colon 6879 59.6 3497 59.5
Rectosigmoid 1186 10.3 616 10.5
Rectum 3483 30.1 1763 30.0
Gender
Male 6246 54.1 3147 53.6
Female 5302 45.9 2729 46.4
Age (years)
p60 1979 17.1 976 16.6
61–70 2912 25.2 1496 25.5
71–80 4147 36.1 2124 36.1
X81 2483 21.5 1280 21.8
Townsend quintile
a (most affluent k most deprived)
1 2273 19.7 1157 19.7
2 2265 19.6 1156 19.7
3 2271 19.7 1157 19.7
4 2270 19.7 1157 19.7
5 2268 19.6 1155 19.7
Unknown 201 1.7 94 1.6
Duke’s stage
b
A/B 4554 39.4 2265 38.6
C/D 5408 46.8 2741 46.7
Unknown 1546 13.7 870 14.8
aPatients’ with unknown Townsend scores were still included in the models by
allocating them the mean score of the study population.
bDuke’s stage was included
as a categorical variable in the models using the groupings A/B, C/D or unknown.
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Figure 1 Adherence of nine Yorkshire colorectal cancer teams to the manual of cancer service standards between 1995 and 2000.
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sTable 2 Median percentage uses of different treatments across the colorectal cancer teams
Chemotherapy in
Dukes C and D patients
Preoperative radiotherapy in
rectal cancer patients
Anterior resection in rectal
cancer patients
Year Median Range Median Range Median Range
1995 34.0 18.0–53.8 0.0 0.0–12.5 46.0 30.0–60.5
1996 38.5 21.9–56.4 9.1 0.0–35.7 50.0 22.7–80.6
1997 35.5 14.3–50.6 11.1 0.0–50.0 59.7 25.8–78.6
1998 43.2 20.8–51.3 19.8 5.0–61.9 55.0 37.9–66.7
1999 41.4 22.2–63.6 22.7 4.0–75.0 55.8 27.3–68.8
2000 36.2 18.2–51.8 17.1 3.3–70.0 53.7 37.5–66.7
Table 3 Odds ratios for the use of chemotherapy in Dukes stage C and D colorectal cancer patients, in relation to the year of diagnosis and the Calman–
Hine implementation scores
1995–2000 1996–1998
Covariate Odds ratio 95% Confidence interval P-value Odds ratio 95% Confidence interval P-value
Year of diagnosis
a 1.18 1.14–1.22 o0.01 1.09 0.78–1.52 0.60
Team score
b per 25% increase 0.92 0.83–1.03 0.15 1.16 0.86–1.58 0.33
Specialisation score
b per 25% increase 1.32 1.02–1.69 0.03 1.03 0.55–1.94 0.92
aOdds ratios adjusted for gender, age, stage of disease, Townsend deprivation score.
bOdds ratios adjusted for gender, age, stage of disease, Townsend deprivation score and
year of diagnosis.
Table 4 Odds ratios for the use of preoperative radiotherapy in the treatment of surgical-treated rectal cancer patients in relation to the year of diagnosis
and the Calman–Hine implementation scores
1995–2000 1996–1998
Covariate Odds ratio 95% Confidence interval P-value Odds ratio 95% Confidence interval P-value
Year of diagnosis
a 1.43 1.33–1.55 o0.01 1.73 1.41–2.12 o0.01
Team score
b per 25% increase 1.58 1.41–1.76 o0.01 0.99 0.70–1.32 0.96
Specialisation score
b per 25% increase 1.43 1.04–1.98 0.04 1.66 0.71–3.88 0.24
aOdds ratios adjusted for gender, age, stage of disease, Townsend deprivation score.
bOdds ratios adjusted for gender, age, stage of disease, Townsend deprivation score and
year of diagnosis.
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Figure 2 Proportion of patients in each of 13 Yorkshire colorectal cancer teams receiving their initial surgery from a colorectal specialist surgeon between
1995 and 2000.
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preoperative radiotherapy were elevated significantly by 43%
(OR¼1.43, 95% CI¼1.04–1.98), suggesting that increasing
surgeon specialisation is linked to an increased use of preoperative
radiotherapy. The effect remained in the reduced collinearity
model, covering the period 1996–1998, but was no longer
statistically significant (OR¼1.66, 95% CI¼0.71–3.88).
Use of anterior resection in rectal cancer patients In 1995, the
median percentage of surgical rectal cancer patients receiving an
anterior resection among all teams was 46.0% (range 30.0–60.5%),
and by 2000 this had increased to a median of 53.7% (range 37.5–
66.7%) (Table 2).
Results from the models developed to investigate changes in the
use of anterior resection in relation to team formation and surgical
site specialisation are summarised in Table 5. No relationship was
observed between increasing adherence to the manual of cancer
service standards and the use of anterior resection. Again, there was
concern about the high correlation between the team score and year
of diagnosis, so a shorter duration model with a reduced collinearity
was explored. Nevertheless, the lack of an effect remained.
There was, however, a statistically significant relationship
between increasing surgical site specialisation and the use of this
operation. A 25% increase in the proportion of patients receiving
their initial surgery from a colorectal specialist was associated with
a 43% increase in the odds of use of anterior resection (OR¼1.43,
95% CI¼1.16–1.76). The effect remained in the reduced
collinearity model (OR¼1.57, 95% CI¼1.00–2.49), although
power was inevitably reduced and the effect was only of marginal
significance.
Five-year survival Across the entire study period, the overall
5-year survival rate was 38.3%. The median 5-year survival rate
across teams was 38.1%, but ranged from 31.1 to 45.4%. Results for
the multilevel models developed to assess whether or not survival
was associated with the Calman–Hine implementations are
summarised in Table 6.
A 25% increase in team score was associated with a statistically
significant 3% reduction in the risk of death for all colorectal
cancer patients (HR¼0.97, 95% CI¼0.94–0.99) and 4% for colon
cancer patients (HR¼0.96, 95% CI¼0.93–0.99). A nonsignificant
1% reduction was observed for rectal cancer patients (HR¼0.99,
95% CI¼0.96–1.01).
There was a trend towards reduced risk of death in relation to
increased surgical site specialisation, particularly for rectal cancer
(HR¼0.93, 95% CI¼0.84–1.03), but the effect failed to reach
statistical significance.
DISCUSSION
Main findings
Between 1995 and 2000, the Calman–Hine recommendations in
terms of team formation and surgical site specialisation were
implemented at varying rates by the colorectal cancer teams of
Yorkshire. Although in some hospitals teams were functioning
according to some Calman–Hine principles from the outset, in no
areas were all the recommendations fully realised by the end of the
study period.
Attempting to determine if these shifts in the organisation of
care were associated with improvements in cancer treatment and
outcome was statistically complex, due to the risk of collinearity
among crucial explanatory variables. However, there was evidence
to suggest that the move towards surgical site specialisation was
associated with the greater use of preoperative radiotherapy and
anterior resection in rectal cancer patients. Small statistically
significant improvements were seen in five-year survival in
relation to increasing adherence to the Manual of Cancer Service
Standards, especially for colon cancer patients. There was a trend
towards improved survival in relation to increasing surgical
specialisation, particularly for rectal cancer patients, but the effect
was not statistically significant. These changes in treatment and
survival relate to 25% increases in the Calman–Hine implementa-
tion scores. The data suggest, therefore, that complete adherence
to the Calman–Hine principles may improve care for colorectal
cancer patients.
Limitations of the study
Deciding on a measure that truly corresponded to the extent
of implementation of the Calman–Hine ideas was difficult. Two
main themes of the original report were, firstly, ensuring that site
specialist doctors and nurses, rather than generalists, managed
patients and, secondly, that all disciplines should meet regularly to
discuss and plan the optimal care pathway for each patient. The
Table 6 Cox proportional hazards models assessing five-year survival in
colorectal cancer patients diagnosed between 1995 and 2000
Covariate
Hazard
ratio
95%
Confidence
interval P-value
Colorectal cancer
Year of diagnosis
a 0.98 0.97–0.99 o0.01
Team score
b per 25% increase 0.97 0.94–0.99 0.01
Specialisation score
b per 25% increase 0.98 0.93–1.04 0.54
Colon cancer
Year of diagnosis
a 0.98 0.96–1.00 0.02
Team score
b per 25% increase 0.96 0.93–0.99 o0.01
Specialisation score
b 1.01 0.94–1.08 0.85
Rectal cancer
Year of diagnosis
a 0.99 0.96–1.01 0.26
Team score
b per 25% increase 0.99 0.95–1.04 0.81
Specialisation score
b per 25% increase 0.93 0.84–1.03 0.15
aHazard ratios adjusted for gender, age, stage of disease, Townsend deprivation
score.
bHazard ratios adjusted for gender, age, stage of disease, Townsend
deprivation score and year of diagnosis.
Table 5 Odds ratios for the use of anterior resection in surgical rectal cancer patients in relation to the year of diagnosis and the Calman–Hine
implementation scores
1995–2000 1996–1998
Covariate Odds ratio 95% Confidence interval P-value Odds ratio 95% Confidence interval P-value
Year of diagnosis
a 1.01 0.96–1.06 0.73 0.96 0.83–1.10 0.53
Team score
b per 25% increase 1.00 0.91–1.10 1.00 0.91 0.76–1.09 0.32
Specialisation score
b per 25% increase 1.43 1.16–1.76 o0.01 1.57 1.00–2.49 0.05
aOdds ratios adjusted for gender, age, stage of disease, Townsend deprivation score.
bOdds ratios adjusted for gender, age, stage of disease, Townsend deprivation score and
year of diagnosis.
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stwo markers chosen were, therefore, surgical site specialisation
and the extent of multidisciplinary team formation. These
measures were seen to be associated with changes in different
processes and outcomes of care. Surgical specialisation was linked
to changes in practice, while teams were associated with an
improvement in survival. This may be a consequence of the
bluntness of these Calman–Hine implementation surrogates but
developing sharper measures to quantify organisational change
is extremely difficult. Our results were, perhaps, predictable.
Surgical site specialisation is associated with greater experience
and training in relation to colorectal cancer and this may result in
heightened awareness of current best practice, thereby encoura-
ging appropriate referral and collaboration with oncologists
explaining the greater use of chemotherapy and radiotherapy, as
well as the use of the ‘gold standard’ surgical procedures. Likewise,
the measurement of the ultimate outcome – survival – was linked
to the team score surrogate. No health professional works in
isolation and survival is dependent on the overall package of care.
Such ideal treatment is reliant not only on good surgeons or
oncologists but also good anaesthetics, pathology, nursing and
generally a good team. Another mechanism via which good teams
may influence outcomes may be due to their influence in situations
where not all team members are specialists. The weekly team
meetings provide a forum for the discussion of each patient and
the advice given ensures that patients are managed optimally by
the nonspecialist team members too. Perhaps these reasons
account for why our team score measure related to improved
survival.
However, the validity of these team scores could be questioned.
They were generated by the collation of data recalled and
researched by each cancer team. While some were meticulous in
their collection, others were (frequently due to time constraints)
more haphazard and, hence, the quality of the results may have
been affected. In addition, we demanded no evidence that the
criteria the teams reported they adhered to had been, in fact,
complied with and, in the current climate, some may have been
tempted to exaggerate their adherence to the new cancer service
recommendations.
There are also questions around what the team score actually
measured. Its composition was based around adherence to
administrative criteria laid out in the Manual of Cancer Service
Standards (Manual of Cancer Service Standards, 2001). Thus, it is
possible that while a team may attain all the criteria, they may still
not have practised as an effective team in the way Calman–Hine
envisaged. Conversely, a team could be working in a collaborative
fashion but fail to adhere to any of the administrative recommen-
dations and so have attained a poor team score. As such, the use of
this team score may be rather a blunt measure.
The alternative Calman–Hine implementation score looking at
surgical site specialisation may also be problematic. The definition
of specialisation chosen was that the surgeons themselves declared
or, if this could not be obtained, workload. The median workload
of the specialist surgeons was only 29 cases per year and this could
be considered low for true colorectal specialists. However, this
figure may not be truly representative as some surgeons worked at
the boundaries of the region and so managed patients who lived
out with the NYCRIS cancer registry region. The data held by the
registry may, therefore, only represent a fraction of their true
patient volume and could reduce the apparent median workload. It
was for this reason that a composite of self-declared specialisation
and workload were used to define the measure. It was not,
however, a perfect method for distinguishing between specialists
and generalists and could again be a rather blunt surrogate. In the
future, perhaps comparing outcomes between named team and
other surgeons would be a more reliable method for distinguishing
between specialists and nonspecialists.
Other issues around data quality are also present. For example,
the NYCRIS data set only contained limited stage information and
no data regarding patient’s existing comorbidities. This could be
considered a flaw as it has been shown that population-based
studies that fail to make adequate adjustment for casemix often
produce inflated outcomes (Halm et al, 2002). However, 86% of the
population could be allocated to a stage group and the study
population exceeded 11500 cases. Although the possibility of bias
cannot be excluded entirely and, as we have no reason to believe
that there are systematic differences in the extent of disease at
diagnosis across the region, the high numbers involved ensure that
the results cannot be attributed to differences in casemix alone.
Similarly, we were limited by the amount of treatment
information available. Again, NYCRIS collects only basic treatment
details and this limited our ability to use pertinent and revealing
outcome measures, for example, whether preoperative radio-
therapy was administered at the optimal dosage to high-risk
patients instead of whether it was given at all. This was
unavoidable, even though NYCRIS possesses one of the most
extensive registry treatment data sets in the UK. The lack of
routine, population-based national data on cancer treatment
remains a general problem.
A final problem with the study is the difficulty of distinguishing
between changes in practice due to the Calman–Hine changes and
those arising from other sources. For example, over the study
period, several papers were published supporting the use of
preoperative radiotherapy and this may account for the increased
use of the treatment over time. It would be impossible to discount
this effect entirely but in all the models a time factor was included
in an attempt to distinguish between innate changes over time and
those due to the Calman–Hine. This time factor was included in all
the models and yet the Calman–Hine implementation scores
remained statistically significant in many analyses. This suggests
the Calman–Hine changes may have induced change over and
above that occurring naturally due to changes in the medical
evidence base or other organisational factors in the NHS.
Comparison with other studies
This study provides some of the first formal evidence to
demonstrate that the Calman–Hine reports recommendations have
been implemented and that these changes have improved NHS
cancer care. It supports previously reported work that suggests that
although initiated, MDTs were still not adhering to all Calman–
Hine recommendations by 2001 (Commission of Health Improve-
ment and the Audit Commission, 2001; National Confidential
Enquiry into Peri-operative Deaths, 2001; Kelly et al, 2003).
Similarly, it supports others measuring the extent of implementa-
tion in terms of surgical site specialisation which have shown that
there has been a move towards surgical specialisation but the shift
is neither uniform, nor complete (Commission of Health Improve-
ment and the Audit Commission, 2001; National Confidential
Enquiry into Peri-operative Deaths, 2001; Jolly et al, 2001).
A strong advantage of this study over others is its use of
population-based data. The majority of studies that have
attempted to assess Calman–Hine reform are all centred on case
series from single units or centres (Shankar et al, 2001; Duxbury
et al, 2003) or surveys of selected populations (Commission of
Health Improvement and the Audit Commission, 2001; National
Confidential Enquiry into Peri-operative Deaths, 2001). Our study
covers the changing practice in many units and centres and
includes over 11000 patients drawn from an area representative of
the UK. As such, it far exceeds the numbers included in any similar
work and could, therefore, be expected to provide more reliable
results.
Implication of findings
This study provides some evidence to suggest that the Calman–
Hine report’s recommendations have improved outcomes in
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scolorectal cancer. However, the work also suggests that un-
acceptable variations in patterns of treatment and outcome
remain and this must be recognised and addressed if
Calman–Hine is to achieve its ultimate aim of a uniformly
high standard of care for all. As there is little reason to suspect that
the situation in Yorkshire is radically different to that across
the rest of the England, it seems fair to assume that our results
reflect the national situation. This work, therefore, provides
cautious support for the current NHS policy of cancer service
reorganisation.
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